SCHEMBL2022647

SCHEMBL2022647

O=C(C=CC1C=CC(O)=CC1)c1c(O)cc(O)cc1O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
CYP3A4 P08684 3/20 0.41
MAPT P10636 2/20 0.41
CHRNA7 P36544 1/20 0.41
SLC5A1 P13866 8/20 0.40
SLC5A2 P31639 8/20 0.40
HPGD P15428 1/20 0.33
FASN P49327 1/20 0.32
KCNA3 P22001 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP19A1 P11511 1/20 0.31
CYP2C9 P11712 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
CYP2C19 P33261 1/20 0.31
PTGS1 P23219 1/20 0.30
DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2019604 0.86 CA12 (0.33) SLC5A1SLC5A2MAOAMAOB
SCHEMBL2023110 0.82 CYP3A4 (0.47) MEN1KMT2ACYP3A4MAPTCHRNA7
SCHEMBL2493332 0.78 MEN1 (0.42) MEN1KMT2ACYP3A4MAPTCHRNA7
SCHEMBL27084458 0.77 MEN1 (0.41) MEN1KMT2ACYP3A4MAPTCHRNA7
SCHEMBL31437614 0.77
SCHEMBL5084410 0.77 MAOA (0.45) MEN1KMT2ACYP3A4MAPTSLC5A1
SCHEMBL2023234 0.76 MAPT (0.44) MEN1KMT2ACYP3A4MAPTCHRNA7
SCHEMBL1076588 0.75 MAPT (0.41) MEN1KMT2ACYP3A4MAPTHPGD
SCHEMBL2020902 0.72 SLC5A1 (0.43) MEN1KMT2ACYP3A4MAPTCHRNA7
SCHEMBL7080592 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9687517-B2 Methods and compositions for treating skin ELC MANAGEMENT LLC (US) 2017-06-27 US claimed
US-20160106795-A9 Methods and Compositions for Treating Skin ELC MANAGEMENT, LLC (US) 2016-04-21 US claimed
US-20150132401-A1 Methods and Compositions for Treating Skin ELC MANAGEMENT, LLC (US) 2015-05-14 US claimed
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS SYMRISE GMBH & CO. KG (DE) 2008-10-02 US claimed
US-9782448-B2 Methods and compositions for treating skin ELC MANAGEMENT LLC (US) 2017-10-10 US disclosed
US-9687517-B2 Methods and compositions for treating skin ELC MANAGEMENT LLC (US) 2017-06-27 US disclosed
US-9445606-B2 Use of 4-hydroxydihydrochalcones and their salts for enhancing an impression of sweetness SYMRISE AG (DE) 2016-09-20 US disclosed
US-20160106795-A9 Methods and Compositions for Treating Skin ELC MANAGEMENT, LLC (US) 2016-04-21 US disclosed
US-9198451-B2 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners SYMRISE AG (DE) 2015-12-01 US disclosed
US-20150132401-A1 Methods and Compositions for Treating Skin ELC MANAGEMENT, LLC (US) 2015-05-14 US disclosed
US-8778987-B2 Use of 4-hydroxychalcone derivatives for masking an unpleasant taste SYMRISE AG (DE) 2014-07-15 US disclosed
US-20140161898-A1 Methods and Compositions for Treating Skin ELC MANAGEMENT, LLC (US) 2014-06-12 US disclosed
EP-2220945-A1 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners Symrise GmbH & Co. KG (DE) 2010-08-25 EP disclosed
US-20100151055-A1 Aroma Composition to Reduce or Suppress Undesirable Bitter and Astringent Taste Impressions of Sweeteners SYMRISE GMBH & CO. KG (DE) 2010-06-17 US disclosed
EP-1998636-B1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO KG (DE) 2010-05-19 EP disclosed
WO-2009082511-A1 METHODS AND COMPOSITIONS FOR TREATING SKIN ELC MANAGEMENT LLC (US) 2009-07-02 WO disclosed
EP-1998636-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS Symrise GmbH & Co. KG (DE) 2008-12-10 EP disclosed
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS SYMRISE GMBH & CO. KG (DE) 2008-10-02 US disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE TAS2R45, TAS2R43, TAS2R30 MEN1 2094/4885KMT2A 3591/4885CYP3A4 940/4885
US-20150132401-A1 Methods and Compositions for Treating Skin LTB4R2, LTB4R, CYSLTR2 MEN1 4799/4885KMT2A 4195/4885CYP3A4 3588/4885
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS TAS2R5, TAS2R20, TAS2R40 MEN1 2488/4885KMT2A 155/4885CYP3A4 541/4885
US-20140161898-A1 Methods and Compositions for Treating Skin LTB4R2, LTB4R, CYSLTR2 MEN1 4799/4885KMT2A 4195/4885CYP3A4 3588/4885
US-20160106795-A9 Methods and Compositions for Treating Skin LTB4R2, LTB4R, CYSLTR2 MEN1 4799/4885KMT2A 4195/4885CYP3A4 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.